Energy News / Shareholders Foundation, Inc.

NASDAQ: BDSI Investor Notice: Investigation over Potential Wrongdoing at BioDelivery Sciences International, Inc.

Via: ReleaseWire

Updated 11:28 AM CDT, Fri, August 09,2019

An investigation on behalf of investors in BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares over potential wrongdoing at BioDelivery Sciences International was announced and NASDAQ: BDSI stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 08/09/2019 -- Certain directors of BioDelivery Sciences International, Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) and currently hold any of those NASDAQ: BDSI shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain BioDelivery Sciences International, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Raleigh, NC based BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioDelivery Sciences International, Inc. reported that its annual Total Revenue declined from $61.18 million in 2017 to $55.64 million in 2018 and that its Net Income of $5.28 million in 2017 turned into a Net Loss of $33.86 million in 2018.

Shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) closed on August 8, 2019 at $4.03 per share.

Those who purchased shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI), have certain options and should contact the Shareholders Foundation.

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-bdsi-investor-notice-investigation-over-potential-wrongdoing-at-biodelivery-sciences-international-inc-1255094.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com